A practical reference on pentapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-02-08 and is reviewed periodically as new material appears.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with C-terminal amide |
| Average mass | Approximately 711.9 Da | Value derived from the formula |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and aqueous acetonitrile | Dissolution aided by acidic diluents |
| Common synonyms | Ipamorelin; NNC 26-0161 | Code name used in early reports |
Lyophilized ipamorelin is generally held at minus twenty degrees Celsius or colder, protected from light and moisture. In solution the peptide is less stable, and degradation proceeds through hydrolysis of the amide backbone, oxidation of the histidine residue, and aggregation. Repeated freeze-thaw cycles accelerate these processes, so dividing material into single-use aliquots before freezing is common practice in research settings. Buffered formulations near neutral pH tend to show the slowest degradation, while strongly acidic or basic conditions raise hydrolysis rates. Stability data specific to ipamorelin are sparse, and much guidance is extrapolated from other short peptides.
Quality control for research-grade ipamorelin is not governed by a single harmonized pharmacopeial monograph, so certificates of analysis vary between suppliers. Common tests include appearance, solubility, water content, peptide content by quantitative amino acid analysis, and residual counterion measurement. Independent verification by an outside laboratory is often used to confirm identity and purity claims. Salt form, counterion content, and residual solvent levels are frequently unspecified, which complicates direct comparison between lots and leaves reproducibility partly unresolved.
Common solvents for laboratory work include water, buffered saline, and dimethyl sulfoxide. Once dissolved, the peptide is exposed to hydrolysis and oxidation, and alkaline conditions accelerate breakdown. Low-binding plasticware and the addition of a carrier protein reduce losses to container surfaces, which can otherwise be substantial at low concentrations. Solutions are typically kept cold and used within days. Investigators working with the compound generally prepare fresh working dilutions rather than storing dilute stocks, and they avoid repeated warming of the same vial.
Reversed-phase high-performance liquid chromatography is the standard method for purity assessment, most often on a C18 column with a water and acetonitrile gradient and trifluoroacetic acid or formic acid as an ion-pairing agent. Mass spectrometry by electrospray or matrix-assisted laser desorption confirms the expected mass and reveals truncated or modified sequences. Amino acid analysis and sequencing provide orthogonal structural evidence. Typical impurities include deletion sequences, oxidized products, and dimeric species. Detection wavelength, usually 214 or 220 nanometers, should be reported because response factors differ between peptides.
Purity is normally reported as a percentage of total peak area, a figure that does not account for water content, residual solvents, or counterions. Trifluoroacetate and acetate are the most frequent counterions in lyophilized peptides, and they shift the true peptide content away from the mass of the powder. A separate quantitative assay is therefore needed to state content accurately. Certificates of analysis often omit these details, which makes batch-to-batch comparison difficult and limits conclusions drawn when results from different suppliers are compared.
La Familia Michoacana was a drug cartel based in Michoacán between at least 2006 and 2011. It was formerly allied with the Gulf Cartel and Los Zetas, but split off to become an independent organization. La Familia Michoacana was the first cartel targeted by President Calderón's security strategy, beginning with Operation Michoacán in December 2006. Between 2009 and 2010, joint U.S.–Mexican operations led to the arrest of hundreds of La Familia members and the reported death of founder Nazario Moreno González ("El Más Loco"). The group soon split between the Knights Templar Cartel and a faction led by José de Jesús Méndez Vargas ("El Chango"), who was arrested in 2011, after which authorities declared La Familia dismantled, leaving the Knights Templar as its de facto successor. In February 2010, La Familia allied with the Gulf Cartel against Los Zetas and the Beltrán-Leyva Cartel. La Nueva Familia Michoacana emerged from splinters of La Familia in the early 2010s, rebranding while continuing operations in Michoacán and Guerrero, and clashing with the Jalisco New Generation Cartel.
== Monazite zonation == Zonation is a characteristic of monazite. A single monazite grain can contain domains of distinctively different compositions and ages. These domains are widely accepted to represent episodes in geological history with monazite growth or recrystallisation. The key to monazite geochronology is to find out what geological events or environments a domain represents, by comparing its chemical composition with mineral stability and reactions. The age of the event is thus represented by the domain age. The ideal formula of monazite is [LREE(PO4)], the variation in composition is mainly due to the chemical substitutions of light rare earth elements (REE) in monazite by other elements. One of the common substitutions are the exchange between LREE with Th and Ca, and P with Si to form huttonite [Th(SiO4)] and brabantite [CaTh(PO4)2]. Since all three minerals share the same chemical structure, they are the three endmembers in their solid solution, meaning that they appear in a same solid phase where substitutions happen. The compositional zonation patterns may not be the same when we are considering different elements, and age zonation may have no relationship with compositional zonation at all. (see images from the section: analysis procedures) Thus, one needs to be very careful in linking among zonations. In natural monazite, the zonation pattern maybe complex and hard to interpret. Below we describe some simple chemical zonation patterns and the associated interpretations. Zonation patterns associated with igneous activity are usually easy to interpret.
Live fish: When live fish are transported they need oxygen, and the carbon dioxide and ammonia that result from respiration must not be allowed to build up. Most fish transported live are placed in water supersaturated with oxygen (though catfish can breathe air directly through their gills and body skin, and the climbing perch has special air-breathing organs). The fish are often "conditioned" (starved) before they are transported to reduce their metabolism and increase packing density, and the water can be cooled to further reduce metabolism. Live crustaceans can be packed in wet sawdust to keep the air humid. By air: Over five percent of the global fish production is transported by air. Air transport needs special care in preparation and handling and careful scheduling. Airline transport hubs often require cargo transfers under their own tight schedules. This can influence when the product is delivered, and consequently the condition it is in when it is delivered. The air shipment of leaking seafood packages causes corrosion damage to aircraft, and each year, in the US, requires millions of dollars to repair the damage. Most airlines prefer fish that is packed in dry ice or gel, and not packed in ice. By land or sea: "The most challenging aspect of fish transportation by sea or by road is the maintenance of the cold chain, for fresh, chilled and frozen products and the optimisation of the packing and stowage density. Maintaining the cold chain requires the use of insulated containers or transport vehicles and adequate quantities of coolants or mechanical refrigeration.
Sources: en.wikipedia.org
=== 2010s onwards === The closure of the Delta hub resulted in several changes at the Memphis airport. Passenger traffic declined from eleven million in 2007 to four million in 2017. The terminal, with its three concourses and unoccupied gates, was too large. In 2014, the Memphis–Shelby County Airport Authority announced a renovation of the airport that would involve modernizing Concourse B and mothballing the other two concourses. On the other hand, airfares dropped and new low-cost airlines entered the market, such as Southwest Airlines. The airport continued to see a high level of cargo activity due to the FedEx hub. As of 2018, Memphis was the second-busiest cargo airport in the world. The refurbishment of Concourse B was completed in February 2022. The building features wider hallways and higher ceilings. The southwest wing of the concourse was not renovated because of cost and a lack of need for the additional gates. Work commenced on an expansion of the landside portion of the terminal in 2024. The program includes tearing down Concourse A to make room for an administrative and baggage-inspection building. Following the death of Frederick W. Smith, founder of FedEx, in June 2025, the airport authority decided to rename the facility in his honor due to his contributions to the city of Memphis and the airport in particular. The Federal Aviation Administration was working on implementing the change as of December 2025. On August 11, 2026, the airport was officially renamed to Frederick W. Smith International Airport.
===== Sendai virus cell entry receptor overexpression ===== Sendai virus cell entry receptors are often overexpressed in cancer cells. SeV receptors are potential biomarkers for evaluation of the vulnerability of malignant cells to the virus. They represented by glycoproteins and glycolipids (see section "SeV cell entry receptors").The expression of some molecules that can facilitate SeV cell entry (see section "SeV cell entry receptors"), frequently, accelerates carcinogenesis or metastasis development. For example, the presence of Sialyl-Lewisx antigen (cluster of differentiation 15s (CD15s)), which is one of SeV cell entry receptors, on the outer cell membrane, correlates with invasion potential of malignant cells, tumor recurrence, and overall patient survival for an extremely wide range of cancers. Therefore, SeV virus preferentially can enter such cells. Metastatic cancer cells frequently express a high density of glycoproteins or glycolipids – molecules that are rich in sialic acid. Expression of the Vim2 antigen, which is another SeV cell entry receptor, is very important for the extravascular infiltration process of acute myeloid leukemia cells. GD1a, ganglioside also serves as SeV receptor and is found in large quantities on the surfaces of breast cancer stem cells. High cell surface expression of another SeV receptor – ganglioside sialosylparagloboside /SPG/ NeuAcα2-3PG. characterizes lymphoid leukemia cells.
Birches native to Eurasia include Betula albosinensis – Chinese red birch (northern + central China) Betula alnoides – alder-leaf birch (China, Himalayas, northern Indochina) Betula ashburneri – (Bhutan, Tibet, Sichuan, Yunnan Provinces in China) Betula baschkirica – (eastern European Russia) Betula bomiensis – (Tibet) Betula browicziana – (Turkey and Georgia) Betula buggsii – (China) Betula calcicola – (Sichuan + Yunnan Provinces in China) Betula celtiberica – (Spain and Portugal) Betula chichibuensis – (Chichibu region of Japan) Betula chinensis – Chinese dwarf birch (China, Korea) Betula coriaceifolia – (Uzbekistan) Betula corylifolia – (Honshu Island in Japan) Betula costata – (northeastern China, Korea, Primorye region of Russia) Betula cylindrostachya – (Himalayas, southern China, Myanmar) Betula dahurica – (eastern Siberia, Russian Far East, northeastern China, Mongolia, Korea, Japan) Betula delavayi – (Tibet, southern China) Betula ermanii – Erman's birch (eastern Siberia, Russian Far East, northeastern China, Korea, Japan) Betula falcata – (Tajikistan) Betula fargesii – (Chongqing + Hubei Provinces in China) Betula fruticosa – (eastern Siberia, Russian Far East, northeastern China, Mongolia, Korea, Japan) Betula globispica – (Honshu Island in Japan) Betula gmelinii – (Siberia, Mongolia, northeastern China, Korea, Hokkaido Island in Japan) Betula grossa – Japanese cherry birch (Japan) Betula gynoterminalis – (Yunnan Province in China) Betula honanensis – (Henan Province in China) Betula humilis or Betula kamtschatica – Kamchatka birch platyphylla (northern + central Europe, Siberia, Kazakhstan, Xinjiang, Mongolia, Korea) Betula insignis – (southern China) Betula karagandensis – (Kazakhstan) Betula klokovii – (Ukraine) Betula kotulae – (Ukraine) Betula luminifera – (China) Betula maximowicziana – monarch birch (Japan, Kuril Islands) Betula medwediewii – Caucasian birch (Turkey, Iran, Caucasus) Betula megrelica – (Republic of Georgia) Betula microphylla – (Siberia, Mongolia, Xinjiang, Kazakhstan, Kyrgyzstan, Uzbekistan) Betula nana – dwarf birch (northern + central Europe, Russia, Siberia, Greenland, Northwest Territories of Canada)) Betula pendula – silver birch (widespread in Europe and northern Asia; Morocco; naturalized in New Zealand and scattered locations in US + Canada) Betula platyphylla – (Betula pendula var. platyphylla) – Siberian silver birch (Siberia, Russian Far East, Manchuria, Korea, Japan, Alaska, western Canada) Betula potamophila – (Tajikistan) Betula potaninii – (southern China) Betula psammophila – (Kazakhstan) Betula pubescens – downy birch, also known as white, European white or hairy birch (Europe, Siberia, Greenland, Newfoundland; naturalized in scattered locations in US) Betula raddeana – (Caucasus) Betula saksarensis – (Khakassiya region of Siberia) Betula saviczii – (Kazakhstan) Betula schmidtii – (northeastern China, Korea, Japan, Primorye region of Russia) Betula sunanensis – (Gansu Province of China) Betula szechuanica – (Betula pendula var. szechuanica)—Sichuan birch (Tibet, southern China) Betula tianshanica – (Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan, Xinjiang, Mongolia) Betula utilis – Himalayan birch (Afghanistan, Central Asia, China, Tibet, Himalayas) Betula wuyiensis – (Fujian Province of China) Betula zinserlingii – (Kyrgyzstan) Note: many American texts have B. pendula and B. pubescens confused, though they are distinct species with different chromosome numbers.
Most fatty acids in the trans configuration (trans fats) are not found in nature and are the result of human processing (e.g., hydrogenation). Some trans fatty acids also occur naturally in the milk and meat of ruminants (such as cattle and sheep). They are produced, by fermentation, in the rumen of these animals. They are also found in dairy products from milk of ruminants, and may be also found in breast milk of women who obtained them from their diet. The geometric differences between the various types of unsaturated fatty acids, as well as between saturated and unsaturated fatty acids, play an important role in biological processes, and in the construction of biological structures (such as cell membranes).
Sources: en.wikipedia.org
=== Angiogenesis for cardiovascular disease === Angiogenesis represents an excellent therapeutic target for the treatment of cardiovascular disease. It is a potent, physiological process that underlies the natural manner in which our bodies respond to a diminution of blood supply to vital organs, namely neoangiogenesis: the production of new collateral vessels to overcome the ischemic insult. A large number of preclinical studies have been performed with protein-, gene- and cell-based therapies in animal models of cardiac ischemia, as well as models of peripheral artery disease. Reproducible and credible successes in these early animal studies led to high enthusiasm that this new therapeutic approach could be rapidly translated to a clinical benefit for millions of patients in the Western world with these disorders. A decade of clinical testing both gene- and protein-based therapies designed to stimulate angiogenesis in underperfused tissues and organs, however, has led from one disappointment to another. Although all of these preclinical readouts, which offered great promise for the transition of angiogenesis therapy from animals to humans, were in one fashion or another, incorporated into early stage clinical trials, the FDA has, to date (2007), insisted that the primary endpoint for approval of an angiogenic agent must be an improvement in exercise performance of treated patients.
=== Flavin adenine dinucleotide === Interacts with the cofactor or prosthetic group, FAD of flavoproteins and contains a flavin moiety in the form of FAD or FMN (flavin mononucleotide). The domain non-covalently binds oxidized FAD or its reduced form, hydroquinone (FADH2).
=== Hybrid documentary === The release of The Thin Blue Line (1988) directed by Errol Morris introduced possibilities for emerging forms of the hybrid documentary. Indeed, it was disqualified for an Academy Award because of the stylized recreations. Traditional documentary filmmaking typically removes signs of fictionalization to distinguish itself from fictional film genres. Audiences have recently become more distrustful of the media's traditional fact production, making them more receptive to experimental ways of telling facts. The hybrid documentary implements truth games to challenge traditional fact production. Although it is fact-based, the hybrid documentary is not explicit about what should be understood, creating an open dialogue between subject and audience. Clio Barnard's The Arbor (2010), Joshua Oppenheimer's The Act of Killing (2012), Mads Brügger's The Ambassador, and Alma Har'el's Bombay Beach (2011) are a few notable examples.
=== Athletics and promotions === Hooters is involved in the sports world. Previous sponsorships include the Miami Hooters, a now defunct Arena Football League team. Hooters formerly sponsored the USAR Hooters Pro Cup, an automobile racing series, and the NGA Pro Golf Tour, a minor league golf tour.
=== As NCCIH (2014–present) === In 2014, while Josephine Briggs was the director, the NCCAM was renamed the National Center for Complementary and Integrative Health (NCCIH). Briggs retired in October 2017. On August 29, 2018, the NCCIH announced Helene Langevin as the new director. She was previously the director of the Osher Center and professor-in-residence of medicine at Harvard Medical School. Her medical interests involve connective tissue. Langevin "believes that the stretching of connective tissue is how several CAM modalities 'work,' such as chiropractic, massage, and ... acupuncture". Langevin has been studying acupuncture since the 1990s. At the time of her appointment, Gorski expressed concern that the balance of power at NCCIH would "shift back towards pseudoscience" with a massive budget to fund the shift. Under Langevin, NCCIH adopted a "whole person health" research framework, investigating how different domains of health—physiology, psychology, and environment—interconnect across the continuum between health and illness. She co-led several trans-NIH initiatives, including the NIH HEAL Initiative on opioid addiction and pain management, and the funding of a Whole Person Reference Physiome and Coordination Center co-funded by 20 NIH Institutes, Centers, and Offices. The NCCIH budget grew to approximately $170 million annually under her leadership. Langevin retired from NCCIH on November 30, 2025, returning to the University of Vermont as director of research at the Osher Center for Integrative Health.
Sources: en.wikipedia.org
It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.
It has not received marketing approval as a medicine in the United States or the European Union. Supplied material is generally described and handled as a research chemical. Regulatory treatment varies by jurisdiction, and some countries restrict growth hormone secretagogues under sports or medicines legislation.
Earlier secretagogues were associated with broader hormonal responses, including measurable changes in cortisol and prolactin. Reports on this peptide describe a narrower profile in which growth hormone release is the most prominent effect. The observation is influential because it shapes how the compound is compared with other members of the same receptor family.
Both molecules activate the same receptor, GHSR-1a, but they share little sequence identity. Ghrelin is a 28-amino-acid hormone carrying a distinctive acyl modification, whereas ipamorelin is a short synthetic peptide. The shared target explains overlapping endocrine effects, while the different structures account for differences in metabolic stability and receptor selectivity.